European Notebook: Piloting Adaptive Pathways; Hepatitis C Pricing; IPO Window
Executive Summary
The first six medicines are selected to pilot Europe’s speedier patient access scheme; France’s proposed health care reforms attract opposition, including a doctors' strike; European biotech companies expect a continuing funding stream from IPOs over the next 12 months.